The Drug Delivery Sector: Reformulating Company Strategies for the Future

Introduction:

The dynamics of the drug delivery market are changing, with pharmaceutical companies bringing drug delivery capabilities in-house. This is driving an evolution in the strategies of the leading players. Datamonitor's analysis provides you with the insight needed to align both your technological and partnership strategy with that of the players most likely to succeed in this changing environment. 

Scope:

* Benchmarks leading drug delivery players by 2001 revenues, R&D spend, operating profits and portfolio value 

* Examines drug delivery company product development and licensing strategies 

* Identifies drivers and resistors of the use of drug delivery technologies, and the factors impacting the future role of drug delivery companies 

* Profiles nine drug delivery companies: Alkermes, Aradigm, Enzon, Nektar, Noven, PowderJect, Sepracor, SkyePharma and Weston Medical 

Report Highlights:

Pharmaceutical companies are taking drug delivery technology in-house, particularly the development of oral controlled and sustained release reformulations. This will drive the classic drug delivery company to evolve its business model in order to retain a competitive edge.  

In a bid for increased profitability, some players will transition to an integrated pharma model, the value of which is highlighted by Sepracor, whose products were rated by Datamonitor as being the most valuable of the companies profiled. 

Companies that do not set up independently will capitalize on the increasing commercialization of biotechnology products, or focus on those niche drug delivery technologies that pharma clients are expected to continue to outsource. 

Reasons to Purchase:

* Benchmark your strategy against key rivals in the drug delivery sector 

* Assess the impact of the changing role of big pharma in the drug delivery sector on your business 

* Understand the technological capabilities of drug delivery companies, and identify possible development partners 

Publisher: Datamonitor Drug Delivery Reports 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_Drug_delivery.html#a122